151 related articles for article (PubMed ID: 25231080)
21. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
22. The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases.
Imai K; Yamashita YI; Miyamoto Y; Nakagawa S; Okabe H; Hashimoto D; Chikamoto A; Baba H
Int J Clin Oncol; 2018 Oct; 23(5):908-916. PubMed ID: 29619592
[TBL] [Abstract][Full Text] [Related]
23. Microwave ablation with or without resection for colorectal liver metastases.
Stättner S; Jones RP; Yip VS; Buchanan K; Poston GJ; Malik HZ; Fenwick SW
Eur J Surg Oncol; 2013 Aug; 39(8):844-9. PubMed ID: 23769976
[TBL] [Abstract][Full Text] [Related]
24. Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome?
Lalmahomed ZS; Ayez N; van der Pool AE; Verheij J; IJzermans JN; Verhoef C
World J Surg; 2011 Mar; 35(3):656-61. PubMed ID: 21161655
[TBL] [Abstract][Full Text] [Related]
25. Role of thrombospondin-1 expression in colorectal liver metastasis and its molecular mechanism.
Teraoku H; Morine Y; Ikemoto T; Saito Y; Yamada S; Yoshikawa M; Takasu C; Higashijima J; Imura S; Shimada M
J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):565-73. PubMed ID: 27404020
[TBL] [Abstract][Full Text] [Related]
26. Surgeon's awareness of the synchronous liver metastases during colorectal cancer resection may affect outcome.
Hamady ZZ; Malik HZ; Alwan N; Wyatt JI; Prasad KR; Toogood GJ; Lodge JP
Eur J Surg Oncol; 2008 Feb; 34(2):180-4. PubMed ID: 17983724
[TBL] [Abstract][Full Text] [Related]
27. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
28. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
[TBL] [Abstract][Full Text] [Related]
29. Liver metastases from colorectal cancer: present surgical approach.
Cavallari A; Vivarelli M; Bellusci R; Montalti R; De Ruvo N; Cucchetti A; De Vivo A; De Raffele E; Salone M; La Barba G
Hepatogastroenterology; 2003; 50(54):2067-71. PubMed ID: 14696466
[TBL] [Abstract][Full Text] [Related]
30. Margin status after laparoscopic resection of colorectal liver metastases: does a narrow resection margin have an influence on survival and local recurrence?
Postriganova N; Kazaryan AM; Røsok BI; Fretland Å; Barkhatov L; Edwin B
HPB (Oxford); 2014 Sep; 16(9):822-9. PubMed ID: 24308605
[TBL] [Abstract][Full Text] [Related]
31. Characterization of early recurrences following liver resection by ALPPS and two stage hepatectomy in patients with colorectal liver-metastases and small future liver remnants; a translational substudy of the LIGRO-RCT.
Røsok BI; Høst-Brunsell T; Brudvik KW; Carling U; Dorenberg E; Björnsson B; Lothe RA; Bjørnbeth BA; Sandström P
HPB (Oxford); 2019 Aug; 21(8):1017-1023. PubMed ID: 30765198
[TBL] [Abstract][Full Text] [Related]
32. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
[TBL] [Abstract][Full Text] [Related]
33. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
34. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
[TBL] [Abstract][Full Text] [Related]
35. Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases.
Gomez D; Zaitoun AM; De Rosa A; Hossaini S; Beckingham IJ; Brooks A; Cameron IC
HPB (Oxford); 2014 Sep; 16(9):836-44. PubMed ID: 24617566
[TBL] [Abstract][Full Text] [Related]
36. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
[TBL] [Abstract][Full Text] [Related]
37. Right and extended-right hepatectomies for unilobar colorectal metastases: impact of portal vein embolization on long-term outcome and liver recurrence.
Ardito F; Vellone M; Barbaro B; Grande G; Clemente G; Giovannini I; Federico B; Bonomo L; Nuzzo G; Giuliante F
Surgery; 2013 Jun; 153(6):801-10. PubMed ID: 23701876
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
[TBL] [Abstract][Full Text] [Related]
39. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.
Halazun KJ; Aldoori A; Malik HZ; Al-Mukhtar A; Prasad KR; Toogood GJ; Lodge JP
Eur J Surg Oncol; 2008 Jan; 34(1):55-60. PubMed ID: 17448623
[TBL] [Abstract][Full Text] [Related]
40. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
